Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
31 results
D3.203 - Yeast surface display as platform for generation of nanobodies to single allergens and allergen extracts
D3.424 - Long-term efficacy and re-sting outcomes following venom immunotherapy discontinuation: A 978-patient analysis
D3.425 - Anaphylactic reaction to carpenter bee
D3.426 - The Frequency of Previous Large Local Reactions in a Group of 158 Patients with a History of Systemic Reaction after Insect Sting
D3.427 - Current practices in diagnosis and treatment of Hymenoptera venom allergy (HVA) in Poland
D3.428 - CAP-Inhibition use to diagnose genuine double sensitization to vespoid venoms: description of a spanish cohort
D2.163 - Effectiveness and safety of Venom ImmunoTherapy (VIT) with “Rapid Cluster” induction protocol
D2.164 - Pediatric bee venom allergy: family background matters
D2.185 - Ultrarush honeybee venom immunotherapy in patients with monoclonal mast cell activation syndrome: two case reports
D2.186 - Toxicity Assessment of Repeated Doses of Apis mellifera Venom for Immunotherapy
D2.269 - Diagnostic challenges in evaluating diagnosis of mast cell disorder in a patient with severe allergy to hymenoptera venom
Pagination
First page
First
Previous page
Previous
Page
1
Current page
2
Download the app
The congress at your fingertips
Available on
Download